3-(三氟甲基)氯甲酸苯酯 | 95668-29-4

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(三氟甲基)氯甲酸苯酯
• 英文名称: 3-(trifluoromethyl)phenyl chloroformate
• 英文别名: [3-(trifluoromethyl)phenyl] carbonochloridate
• CAS: 95668-29-4
• 化学式: C₈H₄ClF₃O₂
• 分子量: 224.567
• InChiKey: VOQHHELXYARECQ-UHFFFAOYSA-N

物化性质

• 沸点：
  201.0±40.0 °C(Predicted)
• 密度：
  1.444±0.06 g/cm3(Predicted)
• 闪点：
  185 °F
• 稳定性/保质期：
  稳定，避免接触强氧化剂。

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险品标志：
  T
• 安全说明：
  S23,S26,S36/37/39,S45
• 危险类别码：
  R23/24/25,R34
• 危险品运输编号：
  UN 3277 6.1/PG 2
• 包装等级：
  II
• 危险类别：
  6.1,8
• 危险性防范说明：
  P501,P260,P270,P262,P234,P271,P264,P280,P284,P390,P361+P364,P303+P361+P353,P301+P330+P331,P301+P310+P330,P304+P340+P310,P305+P351+P338+P310,P403+P233,P406,P405
• 危险性描述：
  H300+H310+H330,H314,H290
• 储存条件：
  2-8℃

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product name : 3-(Trifluoromethyl)phenyl chloroformate

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
According to Regulation (EC) No1272/2008
Acute toxicity, Inhalation (Category 3)
Acute toxicity, Dermal (Category 3)
Acute toxicity, Oral (Category 3)
Skin corrosion (Category 1B)
According to European Directive 67/548/EEC as amended.
Toxic by inhalation, in contact with skin and if swallowed. Causes burns.
Label elements
Pictogram
Signal word Danger
Hazard statement(s)
Toxic if swallowed.
Toxic in contact with skin.
Causes severe skin burns and eye damage.
Toxic if inhaled.
Precautionary statement(s)
Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
Wear protective gloves/ protective clothing/ eye protection/ face protection.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Immediately call a POISON CENTER or doctor/ physician.
Hazard symbol(s)
T Toxic
R-phrase(s)
R23/24/25 Toxic by inhalation, in contact with skin and if swallowed.
R34 Causes burns.
S-phrase(s)
S23 Do not breathe vapour.
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36/37/39 Wear suitable protective clothing, gloves and eye/face protection.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
Other hazards
Lachrymator.

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Formula : C8H4ClF3O2
Molecular Weight : 224,56 g/mol
CAS-No. EC-No. Index-No. Classification Concentration
3-(Trifluoromethyl)phenyl chloroformate
95668-29-4 - - Acute Tox. 3; Skin Corr. 1B; -
H301, H311, H314, H331
T, R23/24/25 - R34
For the full text of the H-Statements mentioned in this Section, see Section 16.

---

Section 4. FIRST AID MEASURES
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Take victim
immediately to hospital. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with water.
Consult a physician.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
For small (incipient) fires, use media such as "alcohol" foam, dry chemical, or carbon dioxide. For large fires,
apply water from as far as possible. Use very large quantities (flooding) of water applied as a mist or spray;
solid streams of water may be ineffective. Cool all affected containers with flooding quantities of water.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
Use water spray to cool unopened containers.

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Wear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Remove all
sources of ignition. Evacuate personnel to safe areas. Beware of vapours accumulating to form explosive
concentrations. Vapours can accumulate in low areas.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and place
in container for disposal according to local regulations (see section 13). Keep in suitable, closed containers
for disposal.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Keep away from sources of ignition - No smoking. Take measures to prevent the build up of electrostatic
charge.
Conditions for safe storage
Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully
resealed and kept upright to prevent leakage.
Recommended storage temperature: 2 - 8 °C

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Personal protective equipment
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with
multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to
engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Hand protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves
after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Eye protection
Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection tested and
approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin and body protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according
to the concentration and amount of the dangerous substance at the specific workplace.
Hygiene measures
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the
product.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Form liquid
Colour colourless
Safety data
pH no data available
Melting point no data available
Boiling point 194 °C at 1.013 hPa
Flash point 85 °C - closed cup
Ignition temperature no data available
Lower explosion limit no data available
Upper explosion limit no data available
Density 1,420 g/cm3
Water solubility no data available

---

Section 10. STABILITY AND REACTIVITY
Chemical stability
Stable under recommended storage conditions.
Conditions to avoid
Heat, flames and sparks.
Materials to avoid
Strong oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, Hydrogen chloride gas,
Hydrogen fluoride

---

Section 11. TOXICOLOGICAL INFORMATION
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
Toxic if inhaled. Material is extremely destructive to the tissue of the mucous
membranes and upper respiratory tract.
Ingestion
Toxic if swallowed. Causes burns.
Skin Toxic if absorbed through skin. Causes skin burns.
Eyes Causes eye burns.
Signs and Symptoms of Exposure
Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and
skin., spasm, inflammation and edema of the larynx, spasm, inflammation and edema of the bronchi,
pneumonitis, pulmonary edema, burning sensation, Cough, wheezing, laryngitis, Shortness of breath,
Headache, Nausea
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Product
This combustible material may be burned in a chemical incinerator equipped with an afterburner and
scrubber. Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
ADR/RID
UN-Number: 3277 Class: 6.1 (8) Packing group: II
Proper shipping name: CHLOROFORMATES, TOXIC, CORROSIVE, N.O.S. (3-(Trifluoromethyl)phenyl
chloroformate)
IMDG
UN-Number: 3277 Class: 6.1 (8) Packing group: II EMS-No: F-A, S-B
Proper shipping name: CHLOROFORMATES, TOXIC, CORROSIVE, N.O.S. (3-(Trifluoromethyl)phenyl
chloroformate)
Marine pollutant: No
IATA
UN-Number: 3277 Class: 6.1 (8) Packing group: II
Proper shipping name: Chloroformates, toxic, corrosive, n.o.s. (3-(Trifluoromethyl)phenyl chloroformate)

---

Section 15. REGULATORY INFORMATION
Causes severe skin burns and eye damage.
Toxic if inhaled.
Skin Corr. Skin corrosion
T Toxic
R23/24/25 Toxic by inhalation, in contact with skin and if swallowed.
R34 Causes burns.
Further information
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee
handling or from contact with the above product. See reverse side of invoice or packing slip for additional
terms and conditions of sale.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(三氟甲基)氯甲酸苯酯 在 吡啶 、 四氮唑 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 生成 [(2R,3S,5R)-5-(4-benzamido-2-oxopyrimidin-1-yl)-3-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]methyl [3-(trifluoromethyl)phenyl] carbonate
  参考文献：
  名称：

  固相寡聚脱氧核苷酸合成：使用过氧阴离子脱保护的两步循环

  摘要：

  开发了一种新型固相亚磷酰胺基寡脱氧核苷酸两步合成方法。该方法的关键是用芳氧基羰基替换 5'-二甲氧基三苯甲基封闭基团，并使用 N-二甲氧基三苯甲基保护腺嘌呤和胞嘧啶的环外胺。通过这些修饰，每个 2'-脱氧核苷 3'-亚磷酰胺与固体支持物上生长的寡脱氧核苷酸偶联后，可以用缓冲在 pH 9.6 的过氧阴离子的水性混合物处理。该试剂有效去除碳酸酯保护基团，同时氧化亚磷酸酯核苷酸间键。因此，新的两步合成循环是可能的。

  DOI：

  10.1021/ja030376n
• 作为产物：
  描述：

  光气 、 间三氟甲基苯酚 在 N,N-二甲基苯胺 作用下， 以 乙酸乙酯 、 甲苯 为溶剂， 反应 1.0h， 生成 3-(三氟甲基)氯甲酸苯酯
  参考文献：
  名称：

  环化活化的前药：N-（取代的2-羟苯基和2-羟丙基）氨基甲酸酯，其基于对乙酰氨基酚的共同前药，即活性苯并恶唑啉酮和恶唑烷酮的开环衍生物。

  摘要：

  分别合成了基于掩蔽的活性苯并恶唑酮（A型）和恶唑烷酮（B型）的N-（取代的2-羟苯基）-和N-（取代的2-羟丙基）氨基甲酸酯，并将其评估为潜在的药物递送系统。制备了一系列与模型A有关的烷基和芳基N-（5-氯-2-羟基苯基）氨基甲酸酯1。这些是骨骼肌松弛药氯唑沙宗的开放药物。相应的4-乙酰氨基苯甲酸酯，名为chlorzacetamol，是氯唑沙宗和对乙酰氨基酚的共同前药。通过将4-乙酰氨基苯基1,2,2,2-四氯乙基碳酸酯与适当的苯胺缩合，可在两步过程中获得氯苯乙胺和其他两种活性苯并恶唑酮和对乙酰氨基酚的互用前药。根据模型B，使用适当的胺类似地获得了对乙酰氨基酚和活性恶唑烷酮的两种互用前药（美他沙酮和美芬沙酮）。发现所有制备的氨基甲酸酯前药在水性（pH 6-11）和血浆（pH 7.4）介质中释放母体药物。在37度水介质中对前药1进行的详细机理研究表明，离去基团ROH的布朗斯台德型关系log t1

  DOI：

  10.1021/jm00020a012

文献信息

• Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
  申请人：——

  公开号：US20030166644A1

  公开（公告）日：2003-09-04

  Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.

  使用化合物抑制激素敏感性脂肪酶，包括这些化合物的药物组合物，使用这些化合物和组合物的治疗方法，以及新化合物。目前的化合物是激素敏感性脂肪酶的抑制剂，可能在治疗和/或预防需要降低激素敏感性脂肪酶活性的医学疾病中有用。
• Substituted piperazines and diazepanes
  申请人：——

  公开号：US20040019039A1

  公开（公告）日：2004-01-29

  A novel class of substituted piperazines and diazepanes, pharmaceutical compositions comprising them and use thereof in the treatment of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.

  一种新型的取代哌嗪和二氮杂环庚烷类化合物，包括它们的药物组合物以及在治疗与组胺H3受体相关的疾病和紊乱中的应用。更具体地说，这些化合物对于治疗需要与组胺H3受体相互作用有益的疾病和紊乱是有用的。
• Thienopyrimidines useful as Aurora kinase inhibitors
  申请人：Lew Willard

  公开号：US20060035908A1

  公开（公告）日：2006-02-16

  The present invention provides compounds having the formula: wherein R 1 , R 2 , X 1 , X 2 , L 1 , L 2 , Y and Z are as defined in classes and subclasess herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.

  本发明提供具有以下公式的化合物： 其中R1、R2、X1、X2、L1、L2、Y和Z的定义如本文中的类和子类中所定义，并且所述的药物组合物，如本文中一般描述和子类中描述的那样，这些化合物可用作蛋白激酶（例如Aurora）的抑制剂，因此可用于治疗由Aurora介导的疾病。
• Quinolines useful in treating cardiovascular disease
  申请人：Collini D. Michael

  公开号：US20050131014A1

  公开（公告）日：2005-06-16

  This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.

  本发明提供了式I化合物的用途，它们在治疗或抑制LXR介导的疾病中是有用的。
• Novel lapachone compounds and methods of use thereof
  申请人：Ashwell Mark A.

  公开号：US20090105166A1

  公开（公告）日：2009-04-23

  The present invention provides novel tricyclic spiro-oxathiine naphthoquinone derivatives, a synthetic method for making the derivatives, and the use of the derivatives to induce cell death and/or to inhibit proliferation of cancer or precancerous cells. The naphthoquinone derivatives of the present invention are related to the compound known as β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione).

  本发明提供了一种新型的三环螺-氧杂硫杂萘醌衍生物，一种制造该衍生物的方法，以及利用该衍生物诱导细胞死亡和/或抑制癌症或前癌细胞增殖的应用。本发明的萘醌衍生物与被称为β-拉帕醇（3,4-二氢-2,2-二甲基-2H-萘(1,2-b)吡喃-5,6-二酮）的化合物有关。